EUVIMED · CrossrefJournal
Canadian IBD Today
ISSN 2817-4135 · Catalytic Health
Latest articles
Recent Clinical Trials in Acute Severe Ulcerative Colitis: Can We Improve the Chances of Success of Corticosteroids and Rescue Therapies?
Optimizing the Risk-benefit Conversation with Inflammatory Bowel Disease Patients
2025: The Inflammatory Bowel Disease (IBD) Year in Review
The Risk of Cardiovascular Complications in Patients with Inflammatory Bowel Disease
JAK inhibitors for the treatment of inflammatory bowel disease
Management of pouchitis: Clinical pearls for the gastroenterologist
Therapeutic drug monitoring of biologics in inflammatory bowel disease
Approach to management of inflammatory bowel disease-related arthritis
Malnutrition assessment in patients with inflammatory bowel disease
Surgical approaches to perianal Crohn's disease
Advanced combination therapy in IBD
Cutaneous manifestations of inflammatory bowel disease
Post-operative Crohn's disease: Current and emerging management techniques
Vaccine-preventable disease in IBD
Bringing STRIDE2 to Life in Clinical Practice
Practical approach to abnormal liver enzymes in patients with inflammatory bowel disease
Colorectal neoplasia surveillance in inflammatory bowel disease
Management of Clostridioides difficile in IBD patients
Today and tomorrow: the use of biomarkers in inflammatory bowel disease
Targeting IL23p19 using risankizumab for the management of moderate-to-severely active Crohn's disease
Selective JAK1 inhibition using upadacitinib for the management of inflammatory bowel diseases
The Rising Burden Of Inflammatory Bowel Disease In Canada
Perioperative Nutritional Considerations In Patients With Inflammatory Bowel Disease
Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease
Bone Health In Patients With Inflammatory Bowel Disease (IBD)
Updates In The Management Of Pediatric Inflammatory Bowel Disease
The Role Of Upfront Surgery in the Management of Ileal Crohn’s Disease
Acute Severe Ulcerative Colitis: Review of Management and Emerging Treatments
Treatment Related Adverse Events and Monitoring of Patients Receiving Biologic or Small Molecule Therapy for Inflammatory Bowel Disease
Medical Management of Inflammatory Bowel Disease in the Elderly
EUVIMED